Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. 薬物名(臨床試験情報から抽出) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Crinecerfont1件: Crinecerfont (Crinecerfont)1件: Crinecerfont (Crinecerfont) 💬 1件: CRHR1 💬 5件: Cushing syndrome, Hormone signaling, Long-term depression, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 81 💬
2Crinecerfont is a novel non-peptide selective corticotropin releasing factor 1 (CRF1 ) receptor antagonist.2件: Corticotropin,
Crinecerfont (Crinecerfont)
3件: Corticotropin ,
Corticotropin, repository ,
Crinecerfont (Crinecerfont) 💬
2件: CRHR1,
MC2R 💬
7件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Long-term depression, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 81 💬
3CrinecerfontProduct Code: NBI-74788 Pharmaceutical Form: Capsule, hardINN or Proposed INN: CrinecerfontCAS Number: 752253-39-7Current Sponsor code: NBI-74788Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 50-Pharmaceutical form of the placebo: CapsuleRoute of administration of the placebo: Oral use----1件: 81 💬